Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Isabella Pisani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Neurology|April 9, 2021
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patientsAnna Isabella Pisani, Antonio Scalfari, Francesco Crescenzo, et al.
Diagnostics (Basel, Switzerland)|December 2, 2020
The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysisMarco Castellaro, Agnese Tamanti, Anna Isabella Pisani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patientsMarco Pitteri, Roberta Magliozzi, Richard Nicholas, et al.
Journal of Neuropsychology|December 1, 2019
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging resultsMarco Pitteri, Caterina Dapor, Anna Isabella Pisani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2021
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple SclerosisDamiano Marastoni, Roberta Magliozzi, Anna Bolzan, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory StudyFrancesco Crescenzo, Damiano Marastoni, Anna Isabella Pisani, et al.
European Journal of Neurology|January 24, 2023
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year studyStefano Ziccardi, Anna Isabella Pisani, Gian Marco Schiavi, et al.
Frontiers in Immunology|August 6, 2019
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal StudyDamiano Marastoni, Alessandro Buriani, Anna Isabella Pisani, et al.
Annals of Clinical and Translational Neurology|January 23, 2021
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosisRoberta Magliozzi, Marco Pitteri, Stefano Ziccardi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2024
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple SclerosisDamiano Marastoni, Ermanna Turano, Agnese Tamanti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Neurology|April 9, 2021
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patientsAnna Isabella Pisani, Antonio Scalfari, Francesco Crescenzo, et al.
Diagnostics (Basel, Switzerland)|December 2, 2020
The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysisMarco Castellaro, Agnese Tamanti, Anna Isabella Pisani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patientsMarco Pitteri, Roberta Magliozzi, Richard Nicholas, et al.
Journal of Neuropsychology|December 1, 2019
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging resultsMarco Pitteri, Caterina Dapor, Anna Isabella Pisani, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2021
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple SclerosisDamiano Marastoni, Roberta Magliozzi, Anna Bolzan, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory StudyFrancesco Crescenzo, Damiano Marastoni, Anna Isabella Pisani, et al.
European Journal of Neurology|January 24, 2023
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year studyStefano Ziccardi, Anna Isabella Pisani, Gian Marco Schiavi, et al.
Frontiers in Immunology|August 6, 2019
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal StudyDamiano Marastoni, Alessandro Buriani, Anna Isabella Pisani, et al.
Annals of Clinical and Translational Neurology|January 23, 2021
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosisRoberta Magliozzi, Marco Pitteri, Stefano Ziccardi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2024
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple SclerosisDamiano Marastoni, Ermanna Turano, Agnese Tamanti, et al.
Pageof 2